Medical devices, healthcare technology and the business of care
510(k) clearance · K260975

Libertas Acetabular Liners (Acetabular Liner)

Maxx Orthopedics, Inc. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK260975

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-10-29 for K260975, a traditional 510(k) submitted by Maxx Orthopedics, Inc. of Norristown, Pennsylvania, covering Libertas Acetabular Liners (Acetabular Liner). The application was received 03/24/2026 and reviewed by the Orthopedic panel under regulation 888.3350, with JDI as the classification product code and LZO and OQI listed as subsequent product codes. Clearance under SESE is not a PMA approval.

The record identifies the device at the category level as a hip prosthesis, semi-constrained, metal/polymer, cemented, and lists no supplement type. The page states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The summary document is linked but its contents are not included here, so materials, sizing, indications and performance data remain unknown from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 29, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260975
Regulatory pathway
510(k) premarket notification
Product code
JDI
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented.

Product code
JDI
FDA device class
2

FDA decision timeline

  1. K260975 received

    Application receipt date recorded by FDA.

  2. K260975 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Maxx Orthopedics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Norristown, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records